Frozen vs Fresh Embryo Transfer: Which Wins?

Frozen embryo transfer (FET) often delivers better success rates and significantly lower OHSS risk than fresh transfer, especially in PCOS patients, high responders, and PGT cases. In Mumbai, FET typically costs ₹60,000 to ₹1,20,000 per transfer. 

According to Dr. Tanuja Uchil, Obstetrician and Gynecologist in Mumbai,
“The choice between fresh and frozen embryo transfer isn’t about which is better in general, it’s about which one suits the patient’s specific cycle, and getting that judgment right is what separates good IVF outcomes from average ones.”

Here’s the core difference

Fresh and frozen embryo transfers differ mainly in the timing and uterine environment at the point of transfer, and this single difference shifts success rates between the two approaches in real cycles. 

• Same Cycle Timing: Fresh embryo transfer places the embryos created right after egg retrieval back into the uterus within 3 to 5 days while the body is still under the hormonal effects of stimulation. This hormonal carryover can sometimes affect just how receptive the uterine lining is at that point in the cycle. 
• Separate Preparation Cycle: Frozen embryo transfer vitrifies the embryos soon after fertilisation and transfers them only in a later cycle once the uterus has been prepared separately through either a natural ovulation cycle or hormone-controlled preparation, which gives a much more receptive endometrial environment.
• OHSS Risk Difference: The risk of ovarian hyperstimulation syndrome is significantly lower with FET, especially for women with PCOS or those who produce a high number of eggs during stimulation, because the transfer is deliberately delayed until hormone levels return fully to baseline.
• Comparable Success Rates: Modern vitrification techniques have made FET success rates either comparable to or slightly better than fresh transfer in most published clinical studies. This is why so many fertility specialists today prefer FET as the default approach in carefully selected cases. 

For most couples in real practice, the choice between fresh and frozen comes down to individual factors like ovarian response, embryo quality, and underlying conditions, rather than just which procedure is “better” in absolute terms on paper.

Frozen embryo transfer is usually recommended in clinical situations where the uterine environment or hormonal state during fresh stimulation is unlikely to support optimal implantation.

• PCOS and OHSS Risk: Women with PCOS or those at high risk of OHSS are routinely advised to opt for FET. Delaying the transfer to a separate cycle gives the body adequate time to recover from stimulation completely and significantly reduces the risk of related complications later on. 
• Planned Genetic Testing: When preimplantation genetic testing (PGT) is planned, FET essentially becomes necessary because embryos need to be biopsied, sent for analysis, and frozen while results are being awaited, which typically takes between 2 to 4 weeks before the actual transfer can happen.
• Elevated Progesterone: Patients with elevated progesterone at the time of trigger injection (a sign of premature luteinisation) often benefit from FET, because high progesterone tends to close the implantation window prematurely and reduces fresh transfer success rates noticeably.
• Uterine Conditions: Conditions like endometriosis, thin endometrium, or hydrosalpinx often need pre-treatment before the transfer can happen safely, and freezing the embryos buys the doctor enough time to optimise the uterine environment without rushing the cycle forward.

Fresh versus frozen decisions are made based on individual cycle response and diagnosis, and for more on what really drives IVF outcomes across different age groups, our blog on IVF success rates by age for Mumbai couples covers this in detail.

Dr.Tanuja Uchil brings over 25 years of obstetrics and gynecology experience, MD from Seth GS Medical College and KEM Hospital, plus further training in reproductive medicine from Kiel, Germany to embryo transfer decisions at OMA Hospital, Mumbai. She leads fertility services at OMA with focus on individualised fresh versus frozen transfer calls made on real-time cycle data rather than fixed standard protocols. Couples wanting to understand the reasoning behind each transfer recommendation in clear plain terms are seen here with full transparency on success rates, OHSS risk, and expected outcomes before the cycle moves forward.

References:

• • Egg Freezing (Oocyte Cryopreservation) – American Society for Reproductive Medicine (ASRM)
  • Fertility Preservation – World Health Organization (WHO)